Prodrugs - Biotechnology: Pharmaceutical Aspects
Latest Publications

TOTAL DOCUMENTS

57
(FIVE YEARS 0)

H-INDEX

5
(FIVE YEARS 0)

Published By Springer New York

9780387497822, 9780387497853
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Case Study: Travoprost: A Potent PGF2α Analog

2008 ◽  
pp. 1359-1368
Author(s):  
Rebecca A. Bross

Case Study: Moexipril Hydrochloride: A Prodrug of Moexiprilat

2008 ◽  
pp. 1289-1297 ◽  
Author(s):  
Bianca M. Liederer

Prodrugs of Alcohols and Phenols

2008 ◽  
pp. 731-799 ◽  
Author(s):  
Sundeep S. Dhareshwar ◽  
Valentino J. Stella

Formulation Challenges of Prodrugs

2008 ◽  
pp. 1083-1110 ◽  
Author(s):  
Robert G. Strickley ◽  
Reza Oliyai

Toxicological Issues with Pivalate Prodrugs

2008 ◽  
pp. 1125-1148
Author(s):  
Eric P. Brass

Case Study: Tenofovir Disoproxil Fumarate: An Oral Prodrug of Tenofovir

2008 ◽  
pp. 1347-1357 ◽  
Author(s):  
Maria Fardis ◽  
Reza Oliyai
Keyword(s):  
Tenofovir Disoproxil Fumarate ◽  
Oral Prodrug

Case Study: Fosamprenavir: A Prodrug of Amprenavir

2008 ◽  
pp. 1241-1249 ◽  
Author(s):  
Hui Ouyang

Prodrugs of Amines

2008 ◽  
pp. 801-831
Author(s):  
Jeffrey P. Krise ◽  
Reza Oliyai

Case Study: Ximelagatran: A Double Prodrug of Melagatran

2008 ◽  
pp. 1395-1402 ◽  
Author(s):  
Olafur S. Gudmundsson

Case Study: Fosphenytoin: A Prodrug of Phenytoin

2008 ◽  
pp. 1259-1267 ◽  
Author(s):  
Valentino J. Stella
Load More ...
Sign in / Sign up

Export Citation Format

Share Document